Resveratrol and its oligomers : modulation of sphingolipid metabolism and signaling in disease

Tools

Lim, Keng Gat and Gray, Alexander I. and Anthony, Nahoum G. and MacKay, Simon P. and Pyne, Susan and Pyne, Nigel J. (2014) Resveratrol and its oligomers : modulation of sphingolipid metabolism and signaling in disease. Archives of Toxicology, 88 (12). pp. 2213-2232. ISSN 0340-5761 (https://doi.org/10.1007/s00204-014-1386-4)

[thumbnail of Final_Resveratrol_and_sphingolipids_in_disease_3_]
Preview
 PDF. Filename: Final_Resveratrol_and_sphingolipids_in_disease_3_.pdf
Accepted Author Manuscript
Download (1MB)| Preview

Abstract

Resveratrol, a natural compound endowed with multiple health-promoting effects, has received much attention given its potential for the treatment of cardiovascular, inflammatory, neurodegenerative, metabolic and age-related diseases. However, the translational potential of resveratrol has been limited by its specificity, poor bioavailability and uncertain toxicity. In recent years, there has been an accumulation of evidence demonstrating that resveratrol modulates sphingolipid metabolism. Moreover, resveratrol forms higher order oligomers that exhibit better selectivity and potency in modulating sphingolipid metabolism. This review evaluates the evidence supporting the modulation of sphingolipid metabolism and signaling as a mechanism of action underlying the therapeutic efficacy of resveratrol and oligomers in diseases, such as cancer.

ORCID iDs

Lim, Keng Gat, Gray, Alexander I., Anthony, Nahoum G. ORCID logoORCID: https://orcid.org/0000-0002-2026-8763, MacKay, Simon P. ORCID logoORCID: https://orcid.org/0000-0001-8000-6557, Pyne, Susan ORCID logoORCID: https://orcid.org/0000-0002-6608-9584 and Pyne, Nigel J. ORCID logoORCID: https://orcid.org/0000-0002-5657-4578;
CORE (COnnecting REpositories)